FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and Unapproved Peptides Lack Safety Data, Regulatory Incentives Misaligned Matt Kaeberlein posted on the topic LinkedIn Research Peptides In Minnesota: Why Not For Human Consumption Doesn't Protect You Holt Law Peptides Lack Reliable Safety Information, Watchdog Warns FDA to weigh easing limits on unproven peptides promoted by RFK Jr.